COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,106,325 | +4.0% | 49,500 | 0.0% | 0.63% | +6.3% |
| Q2 2023 | $1,063,755 | -10.4% | 49,500 | 0.0% | 0.59% | -28.0% |
| Q1 2023 | $1,187,505 | +3.4% | 49,500 | 0.0% | 0.82% | -27.8% |
| Q4 2022 | $1,148,400 | +4.7% | 49,500 | -27.7% | 1.14% | +0.8% |
| Q3 2022 | $1,097,000 | -2.9% | 68,500 | +13.2% | 1.13% | +242.2% |
| Q4 2021 | $1,130,000 | +54.8% | 60,500 | +63.5% | 0.33% | +76.9% |
| Q3 2021 | $730,000 | +242.7% | 37,000 | +311.1% | 0.19% | +220.7% |
| Q2 2021 | $213,000 | 0.0% | 9,000 | 0.0% | 0.06% | -19.4% |
| Q1 2021 | $213,000 | +18.3% | 9,000 | 0.0% | 0.07% | -4.0% |
| Q4 2020 | $180,000 | +260.0% | 9,000 | +275.0% | 0.08% | +212.5% |
| Q3 2020 | $50,000 | -9.1% | 2,400 | -23.8% | 0.02% | -22.6% |
| Q2 2020 | $55,000 | – | 3,150 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |